Literature DB >> 10735263

Sample size in guidelines trials.

J M Bland1.   

Abstract

In clinical trials, the statistical concepts of significance and power are used in the determination of sample size for trials. The trialist must provide an estimate of standard deviation and a hypothetical population difference to be detected. This must be modified to deal with the designs encountered in guideline research. These are cluster randomized trials, because the patients of a single doctor or practice form a cluster. The trialist must be able to provide information about the effects of clustering, in the form of an intraclass correlation coefficient.

Entities:  

Mesh:

Year:  2000        PMID: 10735263     DOI: 10.1093/fampra/17.suppl_1.s17

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  13 in total

Review 1.  Design and analysis of group-randomized trials: a review of recent methodological developments.

Authors:  David M Murray; Sherri P Varnell; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

2.  Methodology for a community-based stroke preparedness intervention: the Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities Study.

Authors:  Bernadette Boden-Albala; Dorothy F Edwards; Shauna St Clair; Jeffrey J Wing; Stephen Fernandez; M Chris Gibbons; Amie W Hsia; Lewis B Morgenstern; Chelsea S Kidwell
Journal:  Stroke       Date:  2014-05-15       Impact factor: 7.914

3.  Cluster Effects in a National Dental PBRN restorative study.

Authors:  M S Litaker; V V Gordan; D B Rindal; J L Fellows; G H Gilbert
Journal:  J Dent Res       Date:  2013-07-15       Impact factor: 6.116

4.  Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.

Authors:  J Fransen; H Bernelot Moens; I Speyer; P L C M van Riel
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

5.  Intraclass correlation coefficients typical of cluster-randomized studies: estimates from the Robert Wood Johnson Prescription for Health projects.

Authors:  David M Thompson; Douglas H Fernald; James W Mold
Journal:  Ann Fam Med       Date:  2012 May-Jun       Impact factor: 5.166

6.  A quasi-randomized group trial of a brief alcohol intervention on risky single occasion drinking among secondary school students.

Authors:  Gerhard Gmel; Vigeli Venzin; Katrin Marmet; George Danko; Florian Labhart
Journal:  Int J Public Health       Date:  2012-10-23       Impact factor: 3.380

7.  A single-blind randomized controlled trial to evaluate the effect of extended counseling on uptake of pre-antiretroviral care in Eastern Uganda.

Authors:  Lubega Muhamadi; Nazarius M Tumwesigye; Daniel Kadobera; Gaetano Marrone; Fred Wabwire-Mangen; George Pariyo; Stefan Peterson; Anna Mia Ekström
Journal:  Trials       Date:  2011-07-27       Impact factor: 2.279

8.  Testing the effectiveness of an innovative information package on practitioner reported behaviour and beliefs: the UK Chiropractors, Osteopaths and Musculoskeletal Physiotherapists Low back pain ManagemENT (COMPLeMENT) trial [ISRCTN77245761].

Authors:  David W Evans; Nadine E Foster; Martin Underwood; Steven Vogel; Alan C Breen; Tamar Pincus
Journal:  BMC Musculoskelet Disord       Date:  2005-07-20       Impact factor: 2.362

9.  Assessment of an enhanced program for depression management in primary care: a cluster randomized controlled trial. The INDI project (Interventions for Depression Improvement).

Authors:  Enric Aragonès; Antonia Caballero; Josep Ll Piñol; Germán López-Cortacans; Waleska Badia; Josep M Hernández; Pilar Casaus; Sílvia Folch; Josep Basora; Antonio Labad
Journal:  BMC Public Health       Date:  2007-09-20       Impact factor: 3.295

10.  A comparison of screening methods for sleep disorders in Australian community pharmacies: a randomized controlled trial.

Authors:  Joanne M Fuller; Keith K Wong; Ronald Grunstein; Ines Krass; Jayshree Patel; Bandana Saini
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.